Ping Mu, Ph.D.
The University of Texas Southwestern Medical Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR170050|
Recruitment of First-Time, Tenure-Track Faculty Members
Memorial Sloan-Kettering Cancer Center
August 16, 2017
Prostate cancer can often be successfully cured by removing the prostate gland and the cancerous tumor within it. But in men whose cancer has already begun to spread beyond the prostate, treating it successfully is much more difficult. Tumors in most patients develop resistance to the primary drug used to treat the disease, and long-term survival rates are low.
Now a researcher who studies how prostate tumor cells develop this resistance is hoping to find new ways of interfering with this cancer’s ability to evolve cells that are resistant to hormone therapy. Molecular biologist Ping Mu was recruited in 2018 to The University of Texas Southwestern Medical Center from Memorial Sloan-Kettering Cancer Center, where he was a postdoctoral researcher.